To further validate whether RIOK2 mediated the inhibitory effects of NSC139021 on glioblastoma cell proliferation, we silenced RIOK2 by using gene-specific siRNAs in U118MG and LN-18 cells. The gene discussed is RIOK2; the disease is glioblastoma.